List of medication management patents

Patent 10452816 was granted and assigned to Catalia Health on October, 2019 by the United States Patent and Trademark Office.

Patent 11244029 was granted and assigned to RxAnte on February, 2022 by the United States Patent and Trademark Office.

Patent 10108975 was granted and assigned to RxAnte on October, 2018 by the United States Patent and Trademark Office.

Patent 6975922 was granted and assigned to Omnicell (company) on December, 2005 by the United States Patent and Trademark Office.

Patent 11640855 was granted and assigned to Omnicell (company) on May, 2023 by the United States Patent and Trademark Office.

Patent 11563333 was granted and assigned to Echo on January, 2023 by the United States Patent and Trademark Office.

Patent 12102596 was granted and assigned to Omnicell (company) on October, 2024 by the United States Patent and Trademark Office.

Patent 11591161 was granted and assigned to Omnicell (company) on February, 2023 by the United States Patent and Trademark Office.

Patent 11426329 was granted and assigned to Omnicell (company) on August, 2022 by the United States Patent and Trademark Office.

Patent 11334902 was granted and assigned to RxAnte on May, 2022 by the United States Patent and Trademark Office.

Patent 11590283 was granted and assigned to Omnicell (company) on February, 2023 by the United States Patent and Trademark Office.

Patent 11536506 was granted and assigned to Omnicell (company) on December, 2022 by the United States Patent and Trademark Office.

Patent 11586997 was granted and assigned to RxAnte on February, 2023 by the United States Patent and Trademark Office.

Patent 10318897 was granted and assigned to RxAnte on June, 2019 by the United States Patent and Trademark Office.

Patent 10051410 was granted and assigned to UnaliWear on August, 2018 by the United States Patent and Trademark Office.

Patent D748088 was granted and assigned to Catalia Health on January, 2016 by the United States Patent and Trademark Office.

Patent 10687193 was granted and assigned to UnaliWear on June, 2020 by the United States Patent and Trademark Office.

Patent 10706372 was granted and assigned to RxAnte on July, 2020 by the United States Patent and Trademark Office.

Patent 11941938 was granted and assigned to Omnicell (company) on March, 2024 by the United States Patent and Trademark Office.

Patent 11970300 was granted and assigned to Omnicell (company) on April, 2024 by the United States Patent and Trademark Office.

Patent 11980748 was granted and assigned to Omnicell (company) on May, 2024 by the United States Patent and Trademark Office.

Patent 12017046 was granted and assigned to Omnicell (company) on June, 2024 by the United States Patent and Trademark Office.